HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM was delisted on the 14th of June, 2023.
24 hedge funds and large institutions have $11.2M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
52% more capital invested
Capital invested by funds: $7.34M → $11.2M (+$3.83M)
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
4% more funds holding
Funds holding: 23 → 24 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.47M |
| 2 |
BWLSA
Blue Water Life Science Advisors
Larkspur,
California
|
+$942K |
| 3 |
CPA
Cowen Prime Advisors
New York
|
+$519K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$346K |
| 5 |
SC
Samjo Capital
New York
|
+$305K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$217K |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$58K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$28.8K |
| 4 |
Morgan Stanley
New York
|
-$8.72K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$1K |
HTGM Hedge Fund Activity: Q1 2021 in Review
24 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in HTG Molecular Diagnostics, Inc. Common Stock (HTGM) for Q1 2021, worth a combined $11.2M — up 52% from $7.34M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HTGM positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $1.47M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $217K sold.
- 24 institutional investors held HTG Molecular Diagnostics, Inc. Common Stock (HTGM) as of Q1 2021, up from 23 in Q4 2020.
- Funds reported $11.2M of HTG Molecular Diagnostics, Inc. Common Stock stock for Q1 2021, up 52% quarter-over-quarter.
- 6 funds opened new HTG Molecular Diagnostics, Inc. Common Stock positions in Q1 2021 and 5 closed out, a net change of +1 holder.
- The largest HTG Molecular Diagnostics, Inc. Common Stock buyer in Q1 2021 was AIGH Capital Management, an estimated $1.47M added.
- The largest HTG Molecular Diagnostics, Inc. Common Stock seller in Q1 2021 was GSA Capital Partners, an estimated $217K sold.
Based on aggregated 13F filings for Q1 2021.